FastWave Medical is a clinical-stage medtech company based in the Minneapolis area, focused on designing next-generation intravascular lithotripsy (IVL) devices to treat calcified coronary and peripheral artery disease. They’ve developed two lead platforms—Artero™ for peripheral arteries and Sola™ for coronary arteries—both engineered to improve deliverability, energy control, and consistency in breaking down hardened plaque. Over $40 million in funding supports their mission to bring safer, more effective IVL tools to interventional cardiologists and vascular surgeons, addressing a market need valued above $10 billion.